Difluprednate Ophthalmic

DRUG2 trials

Sponsors

Thomas M. Lietman, University of California, San Francisco

Conditions

Bacterial KeratitisKeratitis Bacterial

Phase 3

Steroids and Cross-linking for Ulcer Treatment

CompletedNCT04097730

Thomas M. LietmanKeratitis Bacterial

Start: 2020-09-24End: 2024-09-18Updated: 2025-02-03

Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction II

Active, not recruitingNCT06271772

University of California, San FranciscoBacterial Keratitis

Start: 2024-07-01End: 2026-12-31Updated: 2025-12-18

Related Papers

Steroids and Cross-Linking for Ulcer Treatment

JAMA Ophthalmology2025-07-241 citations

Double-masked, sham and placebo-controlled trial of corneal cross-linking and topical difluprednate in the treatment of bacterial keratitis: Steroids and Cross-linking for Ulcer Treatment Trial (SCUT II) study protocol

BMJ Open Ophthalmology2021-11-019 citations